Health stocks hit after Trump taps RFK Jr for top job
The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, while UK-listed firms AstraZeneca and GSK dropped 2% or more. Russ Mould, investment director at AJ Bell, said the pick had “spooked” shareholders, despite questions about how the new administration might pursue its threats.
New York City Eric Adams visited "The View" Friday to give his thoughts on President-elect Donald Trump's presidency and what ...
RFK Jr.'s nomination as head of Department of Health and Human Services spotlights unorthodox health views, but scientists ...
Trump is expected to make Matt Gaetz his attorney general and Marco Rubio his secretary of state, and place Tulsi Gabbard, ...
His ideas may sound good on bumper stickers but are unserious and often downright harmful,” Dr. Ashish K. Jha, dean of Brown ...
Cheryl Hines is sticking by her man, according to a new photo from TMZ that shows the Curb Your Enthusiasm actress partying ...
WASHINGTON — In the hours after President-elect Donald Trump announced that vaccine skeptic Robert F. Kennedy Jr. was his ...
After his 2008 victory over John McCain, Obama's team viewed Kennedy as a leading candidate for EPA Administrator, a key role ...
Robert F. Kennedy Jr.’s push to strip processed food out of school lunch and limit food dye marks a shift in how Trump is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback